The Latest Breaking News from diabetes

Health check, which looks for signs of illnesses such as heart disease and diabetes, is available to people over 40

The drug semaglutide, commonly known by the brand names Ozempic or Wegovy, was originally developed to help people with type 2 diabetes manage their blood sugar levels.

Health experts are more worried about diabetes than before because the onset of the disease has migrated to younger individuals these days. This silent epidemic is bringing quality life to a halt for many individuals at a young age. What is more concerning is that though a lot is being…

Researchers have now found that certain classes of weight loss and diabetes medications could be lifesavers for stroke survivors, slashing their risk of future heart attacks, strokes, and even death.

Diabetes has hit an all-time high in India, with more than 101 million individuals diagnosed with the chronic illness. According to an ICMR survey, the number has climbed by 44% during the last four years. Living with diabetes requires tracking daily glucose fluctuations, making lifestyle changes, and being aware of…

Diabetes and obesity are lifestyle conditions that cause significant metabolic disturbances. If not managed, they can be precursors to serious ailments including, cardiovascular, kidney liver diseases, hormonal disturbances and others. While diabetes has always been identified as a chronic metabolic disorder, obesity is now gradually being recognised as a diseased…

Night Club, which has helped more than 10,000 workers recover their physical and psychological wellbeing, now has four demands for Labour

If Trump’s re-election is getting you down, these innovations in medicine and technology should cheer you up

Women with polycystic ovary syndrome, also known as PCOS and obesity are more likely to have smaller babies in terms of birth weight, length, and head NTNU. Read further on Dynamite News:

Globally, one in eight people are living with obesity. This is an issue because excess fat increases the risk of type 2 diabetes, heart disease and certain cancers.

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted Wednesday strong third-quarter earnings despite being held back by production constraints.